Sales & Marketing News | pharmaphorum

News

Activist investor Starboard builds $1bn Pfizer stake

The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group Pfizer and wants strategic changes to restore growth.

News

Blue Shield of California bypasses PBMs to slash Humira pric...

Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers to slash the price of Humira by up to 90%

News

Amgen to face investor lawsuit over $10.7bn tax liability di...

A federal judge in New York has ruled that Amgen must answer to claims of

News

BMS ends decades-long drought in novel schizophrenia drugs

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal.

News

AZ gets sought-after lung cancer approval for Tagrisso

AstraZeneca's EGFR inhibitor Tagrisso has been approved by the FDA for a new lung cancer indication that could make it a go-to therapy for a patient population that until now had no targete

News

Second Niemann-Pick approval brings more hope to patients

In the space of four days, the number of FDA-approved therapies for ultra-rare genetic disorder Niemann-Pick disease has gone from zero to two, transforming the prospects for patients.

Activist investor Starboard builds $1bn Pfizer stake

Blue Shield of California bypasses PBMs to slash Humira pric...

Amgen to face investor lawsuit over $10.7bn tax liability di...

BMS ends decades-long drought in novel schizophrenia drugs

AZ gets sought-after lung cancer approval for Tagrisso

Second Niemann-Pick approval brings more hope to patients

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks